Track every company, trial, and deal shaping the future of longevity.
LongevityHub Pro gives investors, researchers, and BD teams a single platform to monitor the longevity industry — with automated data from 7 intelligence modules, updated continuously.
No credit card required. Cancel anytime.
Trusted by professionals tracking the longevity industry
The longevity industry moves fast. Keeping up shouldn't be a full-time job.
The longevity sector is fragmented across PubMed, ClinicalTrials.gov, press releases, bioRxiv, and dozens of newsletters. Professionals are spending hours a week piecing together intelligence that should take minutes. LongevityHub Pro does the aggregation, filtering, and summarization for you.
Seven modules. One platform.
Clinical Trials Monitor
Track every longevity-related clinical trial globally — phase, status, sponsor, and AI plain-English summaries.
Companies Database
Profiles for 500+ longevity companies with funding history, focus area, key investors, and latest news.
Funding Tracker
Every investment round in the longevity space with investor details and a 'why this matters' summary.
Research Digest
Curated papers from Nature Aging, Cell, NEJM, and bioRxiv — filtered for quality and summarized for professionals.
News Feed
AI-curated longevity news scored for relevance, categorized, and summarized — updated daily.
People & Movers
Track key hires, departures, and board appointments across leading longevity companies and research institutions.
Regulatory & Policy Watch
Monitor FDA guidance, NIH budget moves, and Congressional activity relevant to longevity therapeutics.
The longevity clinical trials database professionals actually want.
ClinicalTrials.gov is powerful but painful. LongevityHub Pro pulls every aging and longevity trial, filters the noise, and presents them in a clean searchable interface with AI summaries. Filter by phase, status, intervention, and sponsor. Export to CSV in one click.
| Trial | Phase | Status |
|---|---|---|
| Dasatinib + Quercetin in Aging | II | Recruiting |
| Rapamycin Long-Term Safety | II | Active |
| Metformin in Healthy Adults | III | Recruiting |
| NAD+ Precursor Trial | I | Completed |
Simple, transparent pricing.
Pro
For individual professionals
or $490/year (2 months free)
- All 7 intelligence modules
- Keyword alerts (up to 10)
- Unlimited bookmarks
- CSV export on all data
- Weekly Pro digest email
- 7-day free trial
Team
For teams of up to 5
or $1,790/year (2 months free)
- Everything in Pro
- 5 team seats included
- Shared bookmarks & annotations
- Priority support
- Bulk data exports
- 7-day free trial
Secure payments via Lemon Squeezy. Cancel anytime. VAT handled automatically.
"We've built LongevityHub Pro because we couldn't find a single place that tracked the longevity industry clearly and without noise. The newsletter grew because others felt the same way. LongevityHub Pro exists for the professionals who need more than a newsletter — they need a real intelligence platform."
In-depth guides for longevity professionals
Frequently asked questions
The longevity industry isn't waiting. Neither should you.
Start your 7-day free trial. No credit card required.
Start Free Trial →